Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCT-A Vascularity in Trabeculectomy: MMC vs Ologen
NCT04493073Phase 1Unknown
- Start
- Dec 2020
- Primary completion
- Dec 2021
01
Overview
Phase 1, randomised, open-label trial (2 arms). Primary endpoint: Conjunctival vascularity changes at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT04493073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04493073.